Latest News

Tuesday, August 21, 2018

MC2 Therapeutics Reports Positive Topline Data for Investigational Topical for Psoriasis

MC2-01 Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) from MC2 Therapeutics A/S achieved its primary and secondary endpoints, according to recently reported top-line data from…

Read the full story

Monday, August 20, 2018

Whale of a Tale: Shark Gets Botox Injections

It may sound fishy, but even sharks can benefit from Botox injections.  Charles E. Crutchfield III, MD, and Crutchfield Dermatology in Eagan, MN recently assisted the veterinary staff at …

Read the full story

Monday, August 20, 2018

Melanoma Research Alliance Seeks Proposals, Funding Available

The Melanoma Research Alliance (MRA) is soliciting proposals that address the gap in translational science (i.e., turning scientific discoveries into tools and/or treatments for high-risk i…

Read the full story

Monday, August 20, 2018

Merix Pharmaceutical Corp: Releev Cold Sore Treatment Now in Convenience Stores

Merix Pharmaceutical Corp’s Releev®1 Day Cold Sore Symptom Treatment is now available in convenience stores, including 7-Eleven and soon in Circle K in the United States. Releev&nb…

Read the full story

Thursday, August 16, 2018

"Phenomenal Gains" in Derm Device Market, Global Market Insights Predicts

Dermatology devices market, an integral vertical of medical equipment space, of late, has been providing lucrative opportunities to the investors to exploit economies of scale. The claim is very well …

Read the full story

Thursday, August 16, 2018

Ortho Dermatologics Resubmits NDA for Duobrii Lotion

Ortho Dermatologics, a division of Bausch Health Companies Inc., has resubmitted a New Drug Application (NDA) to the FDA for Duobrii™ (halobetasol propionate and tazarotene; …

Read the full story

Wednesday, August 15, 2018

Special to Practical Dermatology: ACS Chief Medical Officer Sounds Off On Sunscreen Misuse

We are getting it all wrong when it comes to our reliance on sunscreen as the be all and end all protection from skin cancer, says Otis W. Brawley, MD, chief medical and scientific officer for the Ame…

Read the full story

Wednesday, August 15, 2018

Revision Skincare Launches DEJ Eye Cream, DEJ Face Cream

Revision Skincare® has created two comprehensive products,DEJ eye cream® and DEJ face cream®, utilizing Pathway Technology and Prebiotic Innovation to provide clinically-proven r…

Read the full story

Wednesday, August 15, 2018

Cynosure to Distribute Porter Instrument's Nitrous Oxide and Oxygen System in Aesthetics Market

Hologic, Inc.'s Cynosure division has penned a deal with Porter Instrument, a business unit of Parker Hannifin Corporation, for distribution rights in the United States and Can…

Read the full story

Tuesday, August 14, 2018

Burt’s Bees Nature-Based Sensitive Skin Care Outperforms MD-Recommended Regimen

Burt’s Bees nature-based sensitive skin regimen is well-tolerated as well as clinically and statistically superior to a leading dermatologist-recommended synthetic regimen, according to a s…

Read the full story

Monday, August 13, 2018

Frequent BCC Linked to Other Cancers

Basal cell carcinoma may increase risk for the development of other cancers, including blood, breast, colon and prostate cancers, according to a preliminary study by researchers at the Stanford Univer…

Read the full story

Monday, August 13, 2018

Escalier Biosciences’ Doses First PsO Patient with ESR-114; Announces Clinical Advisory Board

The first patient has been dosed in a Phase 1/2a study evaluating Escalier Biosciences’ ESR-114 topical gel for mild-to-moderate psoriasis. "The initiation of this study represents a sig…

Read the full story

Monday, August 13, 2018

Pulse Biosciences: First Patient Treated in BCC Study

The first patient has been treated in a clinical study to evaluate Nano-Pulse Stimulation (NPS) from Pulse Biosciences, Inc. for the treatment of Basal Cell Carcinoma (BCC). N…

Read the full story

Friday, August 10, 2018

Neova Introduces Clinical Recovery Cream

Neova SmartSkinCare is launching its Clinical Recovery range of products. The line of six new products is formulated to keep skin calm, soothed, hydrated, and protected following microdermabrasion, la…

Read the full story

Thursday, August 09, 2018

Castle Creek Pharmaceuticals Gets FDA Fast Track Designation for Diacerein 1% Ointment for EBS

The U.S. Food & Drug Administration (FDA) granted fast track status to Castle Creek Pharmaceuticals, LLC’s diacerein 1%, ointment (CCP-020) for the treatment of epidermolysis bullosa simplex…

Read the full story
Load More